Companies · Other Health Care

Sight4All, Inc.

COLUMBUS · Other Health Care

Diligence memoA one-page analyst read on Sight4All, Inc. — recommendation, valuation, rhythm, risks.
$8.8M
Total raised · real
6
Rounds
1.4×
Latest step-up
Top 28%
Sector rank · raised
Seed
Latest stage · inferred · Wed Feb 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Sight4All, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.70× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.4 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Sight4All, Inc. is one of 5377 Other Health Care companies tracked from COLUMBUS. By capital raised it ranks in the upper tier (ahead of 73% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
41
Investors (latest)
2023-02-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2016-07-01 Raised $702K (real) Modeled valuation $22M (est)Pre-Seed2016Pre-Seed · 2016-07-01 Raised $702K (real) Modeled valuation $22M (est)Pre-Seed2016Seed · 2017-07-01 Raised $1.5M (real) Modeled valuation $37M (est)Seed2017Seed · 2018-07-01 Raised $1.5M (real) Modeled valuation $37M (est)Seed2018Seed · 2020-06-30 Raised $795K (real) Modeled valuation $20M (est)Seed2020Seed · 2020-08-04 Raised $1.8M (real) Modeled valuation $43M (est)Seed2020Seed · 2020-08-04 Raised $1.7M (real) Modeled valuation $41M (est)Seed2020Seed · 2023-02-01 Raised $2.5M (real) Modeled valuation $20M (est)Seed2023+$702K+$1.5M+$1.5M+$795K+$1.8M+$1.7M+$2.5MCumulative $11M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$702K · 2016
Pre-Seed extension$702K · 2016
Seed$1.5M · 2017
Seed extension$1.5M · 2018
Seed extension$795K · 2020
Seed extension$1.8M · 2020
Seed extension$1.7M · 2020
Seed extension$2.5M · 2023

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$20.5M
Base estimate est.
$2.1M
Conservative case
$79.8M
Upside case
$12.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $21.6M · 2016-07-012016Pre-Seed · modeled $21.6M · 2016-07-01Seed · modeled $37.2M · 2017-07-01Seed · modeled $37.2M · 2018-07-01Seed · modeled $19.7M · 2020-06-30Seed · modeled $42.7M · 2020-08-04Seed · modeled $41.4M · 2020-08-04Seed · modeled $20.5M · 2023-02-012023
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
3.4 yr
Elapsed time used
3.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$1.3M/yr
Capital velocity
10.0 yr
On record since
2016
First round
8
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.6× above median
This company$8.8M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 1.5× above median
This company$2.5M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.9× of median
This company$20.5M
Sector median$22.1M

Raised more than 73% of sector peers (real $). Modeled value above 49% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #43 of 244.

This companyCohort peer
$10.0M$100.0M$1.0M$10.0MCapital raised (log)Elmntri LLC · Seed Raised $4.0M · modeled $46.1M (est)Atreo, Inc. · Seed Raised $3.8M · modeled $42.1M (est)descendantsDNA, Inc. · Seed Raised $3.4M · modeled $40.8M (est)Westover Project Investor LLC · Seed Raised $4.0M · modeled $40.0M (est)Dentulu Inc · Seed Raised $6.4M · modeled $37.7M (est)Emmacare.com LLC · Seed Raised $3.0M · modeled $37.2M (est)IR-Med, Inc. · Seed Raised $5.4M · modeled $37.0M (est)SDH Parent 2 LLC · Seed Raised $3.0M · modeled $36.7M (est)TecTraum, Inc. · Seed Raised $7.8M · modeled $36.7M (est)DBN BCS II Investments, LLC · Seed Raised $3.0M · modeled $34.0M (est)USRC Baldwin Hills, LLC · Seed Raised $2.8M · modeled $34.0M (est)Flex Operating Room, Inc. · Seed Raised $6.2M · modeled $31.9M (est)Sight4All, Inc. (this company) Raised $8.8M · modeled $20.5M (est)Sight4All, Inc.
CompanyStageRaised · realValue · estvs peer med.
Elmntri LLCSeed$4.0M$46.1M3.83×
Atreo, Inc.Seed$3.8M$42.1M3.50×
descendantsDNA, Inc.Seed$3.4M$40.8M3.40×
Westover Project Investor LLCSeed$4.0M$40.0M3.33×
Dentulu IncSeed$6.4M$37.7M3.13×
Emmacare.com LLCSeed$3.0M$37.2M3.10×
IR-Med, Inc.Seed$5.4M$37.0M3.08×
SDH Parent 2 LLCSeed$3.0M$36.7M3.05×
TecTraum, Inc.Seed$7.8M$36.7M3.05×
DBN BCS II Investments, LLCSeed$3.0M$34.0M2.83×
USRC Baldwin Hills, LLCSeed$2.8M$34.0M2.82×
Flex Operating Room, Inc.Seed$6.2M$31.9M2.65×
Sight4All, Inc. this companySeed$8.8M$20.5M1.70×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$702K2016-07-01$3.9M$21.6M85%
Pre-Seed$702K2016-07-01$3.9M$21.6M85%
Seed$1.5M2017-07-01$7.5M$37.2M90%
Seed$1.5M2018-07-01$7.5M$37.2M90%
Seed$795K2020-06-30$4.0M$19.7M90%
Seed$1.8M2020-08-04$9.0M$42.7M90%
Seed$1.7M2020-08-04$8.7M$41.4M90%
Seed$2.5M2023-02-01$12.5M$20.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$702K2016-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$702K2016-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Seed$1.5M2017-07-01
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • Switched to Rule 506(c) (was Rule 506(b)).
  4. Seed$1.5M2018-07-01
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 506(c)).
  5. Seed$795K2020-06-30
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  6. Seed$1.8M2020-08-04
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • 13 investors on this round.
  7. Seed$1.7M2020-08-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 11 investors on this round.
  8. Seed$2.5M2023-02-01
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 41 investors on this round.
Intelligence
2024 ~Q1
Modeled next raise · ~11mo cadence
$3.6M
Modeled next size est.range $2.5M$5.8M
1.4×
Last step-up
$1.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Tyler Stowater6 other2020-06
Brad Beasecker5 other2020-06
Mark Rossi4 other2020-08
Robin Sears3 other2020-06
E. Dean Butler2 other2020-08
Christopher Birosak2018-07
Christopher Paul Birosak2017-07
Grady Lenski2023-02
Jean Murrer2016-07
Jean Paul Murrer2017-07
Jessica Murrer2016-07
Ken Dean Baker2020-08
Kenneth D. Baker2023-02
Martin Murrer2016-07
Reed Miller2023-02
Robert Bevington2016-07
Robert K. Eastlack2023-02
Robert Paul Bevington2017-07
Stephen Paul Wallace2017-07
Stephen Wallace2016-07
Registry & provenance

Sight4All, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1669321
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Lentechs LLCOther Health CareSeed$5.1M$12.0Mnetwork3 shared operators · same sector · same stage
Myoptechs, Inc.Other Health CareSeed$1.3M$5.3Mnetwork2 shared operators · same sector · same stage
PFO Global, Inc.Other Health CareSeed$8.6M$7.8Mnetwork1 shared operator · same sector · same stage
Rio Grande Neurosciences, Inc.Other Health CareSeed$8.9M$20.5Msame sector · same stage
Green Sun Holdings, LLCOther Health CareSeed$7.6M$19.3Msame sector · same stage
Vitranu, Inc.BiotechnologySeed$1.5M$33.0Mnetwork2 shared operators · same stage
Entrada, Inc.Other Health CareSeed$10.5M$18.6Msame sector · same stage
StartBox LLCOther Health CareSeed$10.5M$19.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
A4L (US), Inc.Other Health CareSeries B$19.0M84%
O/D Vision, Inc.Other Health CarePre-Seed$3.4M84%
All4Cure, Inc.Other Health CarePre-Seed$3.1M83%
Assisted 4 Living, Inc.Other Health CareSeries A$62.2M83%
MediCanna Vision Inc.Other Health CareSeed$4.1M83%
At4K, LlcOther Health CareSeed$10.5M83%
SeeThru IncOther Health CarePre-Seed$3.4M83%
Sight Vision Partners, LLCHospitals and PhysiciansSeed$18.9M83%
Frequently asked
How much funding has Sight4All, Inc. raised?
Sight4All, Inc. has raised approximately $8.8M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Sight4All, Inc.'s estimated valuation?
Provath's modeled valuation for Sight4All, Inc. is approximately $20.5M (modeled range $2.1M–$79.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Sight4All, Inc. at?
Sight4All, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Wed Feb 01.
What does Sight4All, Inc. do and where is it based?
Sight4All, Inc. operates in the Other Health Care sector, based in COLUMBUS.
Explore related

See where Sight4All, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Sight4All, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.